2023 annual financial data
ADC Therapeutics 2023 Operating margin
ADC Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -238.63%.
Operating income was -165,986,000 USD and net income was -240,053,000 USD.
Operating cash flow was -118,686,000 USD.
Get free ADC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 69,558,000 USD
- Operating income
- -165,986,000 USD
- Net income
- -240,053,000 USD
- Operating cash flow
- -118,686,000 USD